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Objective: To review the evidence as to whether exercise, both 
during and after cancer treatment, improves cancer-related 
fatigue in adults. Data sources: The Cochrane Controlled 
Trials Register, MEDLINE, EMBASE, CINAHL, British 
Nursing Index, AMED, SIGLE, and Dissertation Abstracts 
International were searched to July 2007. This search was 
supplemented by hand searching relevant journals and 
contacting experts. Study selection: Randomised controlled 
trials that investigated the effect of exercise on cancer-
related fatigue in adults. The primary outcome measure 
was fatigue, and secondary outcome measures included 
aerobic capacity/cardiovascular function, quality of life, 
body composition, physical activity levels, general mood, 
depression and anxiety. Data extraction: Two review 
authors independently assessed the methodological quality 
of studies and extracted data based upon pre-defined criteria. 
Any discrepancies were reviewed by a third review author to 
reach consensus. Methodological quality was assessed using 
the Oxford Quality Scale. Data synthesis: 28 studies were 
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identified for inclusion (n = 2083 participants) in the review. 
A meta-analysis was used to combine the post-test results 
of the 28 studies, with 30 comparisons possible due to the 
inclusion of two intervention groups in two studies. Based 
on the quantitative pooling of the available data from these 
trials, 22 comparisons provided data for 920 participants 
who received an exercise intervention, and 742 participants 
in the control arm. At the end of the intervention period 
there was a statistically significant difference in fatigue, 
in favour of exercise (SMD –0.23, 95% CI –0.33 to –0.13). 
Exercise was statistically more effective than the control 
intervention whether it was carried out during cancer 
treatment (SMD –0.18, 95% CI –0.32 to –0.05) or following 
cancer treatment (SMD –0.37, 95% CI –0.55 to –0.18). In 
addition, statistically significant beneficial effects were 
identified specific to a population with breast cancer (n = 16 
studies, 1172 participants). Comparisons were not possible 
in the remaining secondary outcomes with variations in 
diagnostic group studied and differences in the quality of 
the study and data reported. Conclusion: Exercise, both 
during and after cancer treatment, appears to have some 
benefit in the management of fatigue, and should therefore 
be considered as a management strategy.
Commentary
Fatigue is a common symptom experienced by cancer 
survivors. Cancer-related fatigue (CRF) is distinguishable 
from normal fatigue in that CRF symptoms are severe, 
distressing, and unrelieved by sleep and rest (Mock et 
al 2000, Cella et al 2001, Stone and Minto 2008). The 
underlying causes and pathophysiology of CRF are unclear 
and it has proven to be a difficult symptom to manage. 
Management strategies include behavioural interventions, 
pharmacological treatments, and exercise programs (Mock 
et al 2000, Cella et al 2001, Stone and Minto 2008).
The overall findings of this review support a small but 
beneficial effect of exercise in reducing symptoms of CRF. 
There are a number of issues, however, to consider before 
drawing conclusions about clinical practice based on this 
review. First, there was a considerable degree of clinical 
heterogeneity between studies in terms of type of cancer, 
mode and intensity of exercise, and timing of the exercise 
intervention. Furthermore, there was significant statistical 
heterogeneity identified for a number of comparisons 
presented in the review. While the authors acknowledge 
this heterogeneity, they do not elaborate on the potential 
effect of the clinical and statistical heterogeneity on their 
findings and conclusions. The individual study findings 
show variability in effect sizes ranging from small to 
large and from beneficial to harmful effects. For example, 
the Thorsen (2005) study (varied cancer population, post 
treatment, home-based program) showed a potentially 
harmful effect of 0.37 (95% CI –0.02 to 0.77) from exercise, 
while the Milne (2008) study (breast cancer, post treatment, 
supervised aerobic and resistance exercise) showed a large 
beneficial effect of –1.35 (95% CI –1.92 to –0.78). Thus, 
the overall finding of a small positive effect of exercise on 
CRF may be misleading as exercise may prove to be more 
or less helpful based on the type of cancer, timing of the 
intervention, and type of exercise program.
The authors acknowledge that few studies focused on fatigue 
as the primary endpoint in cancer survivors. Consequently, 
we may have evidence that exercise has a small beneficial 
effect on fatigue in the general population of cancer survivors 
but limited evidence that exercise can reduce CRF in cancer 
survivors with CRF, especially severe CRF. The findings 
of this review, while providing preliminary evidence in 
support of exercise, highlight the need for further research 
in clearly defined cancer populations with CRF.
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